Global report - October 5, 2016
EU-US collaboration to combat rare diseases
The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have set up a new ‘cluster’ on rare diseases to share experiences and best practices on each other’s regulatory approach to the development of medicines for these diseases. While rare diseases are estimated to affect 30 million people in the European […]
